The Challenge of Managing Ischemic Stroke in Brucellosis: a Case Report

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Mar 27

PMID 38533516

Authors

Linfa Chen

Xiaolong Lin

Xiuqu Cai

Shiting Zeng

Yanquan Yuan

Zhiyong Huang

Jinjin Yan

You Li

Affiliations

Soon will be listed here.

Abstract

A 64-year-old woman was admitted to the hospital for sudden weakness in one of her left limbs. The patient was diagnosed with acute ischemic stroke (IS) of undetermined cause and received intravenous thrombolysis. Following thrombolysis, the patient's left limb weakness improved, but she subsequently developed recurrent high fever and delirium. Further diagnostic tests revealed that she had been infected with . The patient showed significant improvement during anti-infection treatment for Brucellosis and secondary prevention treatment for IS. However, her condition unexpectedly worsened on the 44th day after admission due to a hemorrhagic stroke (HS), which required an urgent craniotomy. Immunohistochemical analysis of the hematoma sample collected during the operation showed the presence of CD4 and CD8 T lymphocytes surrounding the blood vessels. This case highlights the unique challenge of managing IS in brucellosis and sheds light on the potential role of T lymphocytes in the immune response related to stroke.

Citing Articles

Diagnosis of early neurobrucellosis using metagenomic next-generation sequencing of the cerebrospinal fluid in nonepidemic zone: Case report and lecture review.

Liu H, Li Q, Ouyang X, Li Q, Min Y, Dai L Medicine (Baltimore). 2025; 104(7):e41481.

PMID: 39960952 PMC: 11835056. DOI: 10.1097/MD.0000000000041481.

Tissue infarction secondary to brucellosis: a systematic review of case reports and case series.

Keyvanfar A, Najafiarab H, Mohammadi Z, Falah Tafti M, Talebian N, Tehrani S BMC Infect Dis. 2025; 25(1):203.

PMID: 39934661 PMC: 11818214. DOI: 10.1186/s12879-025-10599-x.

References

Soares C, da Silva M, Lima M . Neurobrucellosis. Curr Opin Infect Dis. 2023; 36(3):192-197. DOI: 10.1097/QCO.0000000000000920. View

Moley C, Chambers C, Dadelahi A, Ponzilacqua-Silva B, Abushahba M, Lacey C . Innate Lymphoid Cells and Interferons Limit Neurologic and Articular Complications of Brucellosis. Am J Pathol. 2023; 193(9):1170-1184. PMC: 10477959. DOI: 10.1016/j.ajpath.2023.05.006. View

Liu Y, Gu Y . Case report: A case of abrupt stroke as the first symptom of neurobrucellosis. Front Neurol. 2023; 14:1066042. PMC: 9992872. DOI: 10.3389/fneur.2023.1066042. View

Guo X, Zeng H, Li M, Xiao Y, Gu G, Song Z . The mechanism of chronic intracellular infection with spp. Front Cell Infect Microbiol. 2023; 13:1129172. PMC: 10151771. DOI: 10.3389/fcimb.2023.1129172. View

Jin M, Fan Z, Gao R, Li X, Gao Z, Wang Z . Research progress on complications of rucellosis. Front Cell Infect Microbiol. 2023; 13:1136674. PMC: 10102637. DOI: 10.3389/fcimb.2023.1136674. View

Alqwaifly M, Al-Ajlan F, Al-Hindi H, Al Semari A . Central Nervous System Brucellosis Granuloma and White Matter Disease in Immunocompromised Patient. Emerg Infect Dis. 2017; 23(6):978-981. PMC: 5443428. DOI: 10.3201/eid2306.161173. View

Zhu Y, Shi L, Zeng Y, Piao D, Xie Y, Du J . Key immunity characteristics of diverse stages of brucellosis in rural population from Inner Mongolia, China. Infect Dis Poverty. 2022; 11(1):63. PMC: 9167523. DOI: 10.1186/s40249-022-00989-7. View

Yagupsky P, Morata P, Colmenero J . Laboratory Diagnosis of Human Brucellosis. Clin Microbiol Rev. 2019; 33(1). PMC: 6860005. DOI: 10.1128/CMR.00073-19. View

Ata F, Yousaf Z, Sharif M, Abdallah A . Demyelinating steroid-responsive neurobrucellosis. BMJ Case Rep. 2020; 13(3). PMC: 7064066. DOI: 10.1136/bcr-2019-233798. View

10.

Yu L, Zhang Z, Zou Y, Qi X, Zhang Y, Bai K . Next-generation sequencing in the diagnosis of neurobrucellosis: a case series of eight consecutive patients. Ann Clin Microbiol Antimicrob. 2023; 22(1):44. PMC: 10239078. DOI: 10.1186/s12941-023-00596-w. View

11.

Goodwin Z, Yang X, Hoffman C, Pascual D . Live mucosal vaccination stimulates potent protection varied CD4 and CD8 T cell subsets against wild-type 16M challenge. Front Immunol. 2022; 13:995327. PMC: 9574439. DOI: 10.3389/fimmu.2022.995327. View

12.

Dadelahi A, Abushahba M, Ponzilacqua-Silva B, Chambers C, Moley C, Lacey C . Interactions between B cells and T follicular regulatory cells enhance susceptibility to Brucella infection independent of the anti-Brucella humoral response. PLoS Pathog. 2023; 19(9):e1011672. PMC: 10538787. DOI: 10.1371/journal.ppat.1011672. View

13.

Laine C, Johnson V, Scott H, Arenas-Gamboa A . Global Estimate of Human Brucellosis Incidence. Emerg Infect Dis. 2023; 29(9):1789-1797. PMC: 10461652. DOI: 10.3201/eid2909.230052. View

14.

Wang H, Hoffman C, Yang X, Clapp B, Pascual D . Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection. PLoS Pathog. 2020; 16(1):e1008176. PMC: 6968852. DOI: 10.1371/journal.ppat.1008176. View

15.

Seidel G, Pardo C, Newman-Toker D, Olivi A, Eberhart C . Neurobrucellosis presenting as leukoencephalopathy: the role of cytotoxic T lymphocytes. Arch Pathol Lab Med. 2003; 127(9):e374-7. DOI: 10.5858/2003-127-e374-NPALTR. View

16.

Shi S, Vodovoz S, Xiu Y, Liu N, Jiang Y, Katakam P . T-Lymphocyte Interactions with the Neurovascular Unit: Implications in Intracerebral Hemorrhage. Cells. 2022; 11(13). PMC: 9266108. DOI: 10.3390/cells11132011. View